- Homepage | Gut
Gut is a leading international journal in gastroenterology and hepatology and has an established reputation for publishing first class clinical research of the alimentary tract, the liver, biliary tree and pancreas
- Online First | Gut
October 20, 2025 Letter Heterogeneity and lack of standardisation in gut microbiome testing: a comparative assessment of French medical biology laboratories Maxime Pichon, Claire Bouleti, MICMAC Study Group SFM, Genevieve Hery-Arnaud, Christophe Burucoa doi: 10 1136 gutjnl-2025-336981
- Authors | Gut
Editorial policies and guidelines for authors seeking to submit to Gut, a leading international journal in gastroenterology and hepatology
- About | Gut
Discover journal metrics, statistics, affiliations and contact information for Gut, a leading international journal in gastroenterology and hepatology
- Gut microbiome and health: mechanistic insights | Gut
In this review, specific attention is given to provide a critical evaluation of the current understanding in this field Numerous molecular mechanisms explaining how gut bacteria might be causally linked with the protection or the onset of diseases are discussed
- Current Issue - Gut
Enterococcus faecalis hijacks FABP2 to activate quorum-sensing signals and aggravate Crohn’s disease by inducing gut dysbiosis (8 June, 2025) Yunwei Sun, Xi Huang, Yakun Zhang, Weiwen Bao, Zheyan Lu, Wenying Zhao, Yusufu Rukeya, Ping He, Ji Qi, Sanhong Liu, Xiaoli Jiang, Ruidong Zhang, Kaiwen Yu, Difan Wang, Yiwen Sun, Guoping Zhao, Qijun Wang
- Integration of lipidomics with targeted, single cell, and spatial . . .
Abstract FREE Full Text Google Scholar ↵ Song M , Zhang X , Meyerhardt JA , et al Marine ω-3 polyunsaturated fatty acid intake and survival after colorectal cancer diagnosis Gut 2017;66:1790–6 doi:10 1136 gutjnl-2016-311990
- British Society of Gastroenterology guidelines on colorectal . . .
Patients with inflammatory bowel disease (IBD) remain at increased risk for colorectal cancer and death from colorectal cancer compared with the general population despite improvements in inflammation control with advanced therapies, colonoscopic surveillance and reductions in environmental risk factors This guideline update from 2010 for colorectal surveillance of patients over 16 years with
|